Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Particulate & foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables.

867 FDA drug recalls with this cause, newest first.

These recalls involve visible foreign material - glass, metal, fibers, rubber or other debris - most often found in injectable or liquid products, where nothing besides the intended ingredients should be present. It also includes foreign tablets or capsules found in a bottle of a different product. In an injectable a stray particle can go straight into the bloodstream, which is why a noticeable share of these recalls are Class I.

Class II · Moderate risk

Fosphenytoin Sodium Injection

Presence of Particular Matter: Potential glass delamination and consistent with glass particulates observed in sample vials.

Terminated Particulate / foreign matter Fresenius Kabi USA, LLC NDC 63323-403-10 D-1429-2014
Class II · Moderate risk

Fosphenytoin Sodium Injection

Presence of Particular Matter: Potential glass delamination and consistent with glass particulates observed in sample vials.

Terminated Particulate / foreign matter Fresenius Kabi USA, LLC NDC 63323-403-02 D-1428-2014
Class II · Moderate risk

Famotidine Injection 20 mg

Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as plastic/rubber in famotidine Injection premixed containers.

Terminated Particulate / foreign matter Baxter Healthcare Corp. NDC 0338-5197-41 D-0293-2015
Class I · High risk

Marcaine (bupivacaine HCl)

Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-1559-10 D-1358-2014
Class I · High risk

1% LIDOCAINE HCl Injection

Presence of Particulate Matter: Confirmed customer complaint that orange and black particulates, identified as iron oxide, were found embedded within the glass vial and floating in solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4279-02 D-0382-2015
Class II · Moderate risk

Pristiq (desvenlafaxine)

Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.

Terminated Particulate / foreign matter Pfizer Us Pharmaceutical Group NDC 0008-1211-30 D-1409-2014
Class II · Moderate risk

Tikosyn¿ (dofetilide)

Presence of Foriegn Tablets/Capsules: A single Tikosyn¿ (dofetilide) 250 mcg capsule was discovered in one bottle of Tikosyn¿ (dofetilide) 500 mcg (0.5 mg).

Terminated Particulate / foreign matter Pfizer Inc. NDC 00069-5820-60 D-1253-2014
Class I · High risk

Propofol Injectable Emulsion

Presence of Particulate Matter: A glass defect was found on the interior neck of the vial during a retain sample inspection where the glass vial contained visible embedded metallic particulate and free floating metallic particulates were also found in solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-30 D-1547-2014
Class II · Moderate risk

Ranitidine Tablets USP

Presence of Foreign Tablets/Capsules: Recall is due to a pharmacist complaint of a "foreign material", identified as Metoprolol Tartrate Tablet USP 50 mg, found co-mingled in a bottle of Ranitidine Tablets USP 150 mg.

Terminated Particulate / foreign matter Glenmark Generics Inc., USA NDC 68462-248-05 D-1229-2014
Class II · Moderate risk

Perrigo

Presence of Particulate Matter Perrigo is recalling seven lots of Clindamycin Palmitate Hydrochloride for Oral Solution 75mg/5ml.

Terminated Particulate / foreign matter Paddock Laboratories, LLC NDC 0574-0129-01 D-1168-2014
Class I · High risk

Venlafaxine HCl Extended-Release Capsules

Presence of Foreign Tablets/Capsules: report of a foreign capsule with markings (TKN 250) and identified as a Tikosyn (dofetilide) capsule was found in a bottle of Effexor XR (venlafaxine HCl) 150 mg capsules that was packaged in the same packaging campaign as the recalled lot

Terminated Particulate / foreign matter Greenstone Llc NDC 59762-0182-2 D-1361-2014
Class I · High risk

Effexor XR

Presence of Foreign Tablets/Capsules: A Pharmacist reported that a bottle of Effexor XR 150 mg capsules contained a single peach colored capsule printed TKN250 which was identified as a Tikosyn (dofetilide) capsule.

Terminated Particulate / foreign matter Pfizer Us Pharmaceutical Group NDC 0008-0836-21 D-1328-2014
Class III · Low risk

Atripla

Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.

Terminated Particulate / foreign matter Gilead Sciences, Inc. NDC 15584-0101-1 D-1090-2014
Class I · High risk

Acetylcysteine Solution

Presence of Particulate Matter: During a review of retain samples, the firm found a glass particulate in one lot of Acetylcysteine Solution

Terminated Particulate / foreign matter Ben Venue Laboratories Inc NDC 0054-3025-02 D-1326-2014
Class II · Moderate risk

etomidate injection

Presence of Particulate Matter: Potential for small black particles to be present in individual vials, the potential for missing lot number and/or expiry date on the outer carton and the potential for illegible/missing lot number and expiry on individual vials.

Terminated Particulate / foreign matter Agila Specialties Private Ltd. NDC 0069-0006-02 D-1225-2014
Class II · Moderate risk

BUPivacaine HCl 0.25% Preservative Free

Presence of Particulate Matter: The bupivacaine HCl injection used to compound this lot of BUPivacaine HCl 0.25% Preservative Free 500 mL in On-Q C-bloc was recalled by the supplier due to a customer complaint of visible particles embedded in the glass vial.

Terminated Particulate / foreign matter Healix Infusion Therapy, Inc. NDC 75901-7210-53 D-1422-2014
Class II · Moderate risk

Atorvastatin Calcium Tablets

Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an Atorvastatin 20 mg tablet inside a sealed bottle of 90-count Atorvastatin 10 mg.

Terminated Particulate / foreign matter Ranbaxy Inc. NDC 63304-827-90 D-1086-2014